Opinion | April 17, 2025
Injection filter needle market to reach $1.73 billion in 2025
Rising demands and advancements in eye care drive growth
Rising demands and advancements in eye care drive growth
YESAFILI, a vascular endothelial growth factor (VEGF) inhibitor, is used to treat several different types of ophthalmology conditions
Susvimo is the first and only continuous delivery treatment that offers an alternative to regular eye injections to treat diabetic macular edema (DME)
Regulatory filings underway for a third indication for darolutamide in prostate cancer, for finerenone in a common form of heart failure, and acoramidis in transthyretin amyloid
Demonstrates vision gains with extended treatment intervals in retinal vein occlusion
Bumetanide Injection USP (RLD Bumex) had an estimated annual sale of USD 20 million in the US
Efficacy and safety from this phase IV study were consistent with data from the Vabysmo phase III DME studies
Bumetanide Injection USP (RLD Bumex) had estimated annual sales of USD 20 million in the U.S.
The campaign targets 63 endemic districts across Bihar, Jharkhand, Karnataka, Odisha, Telangana, and Uttar Pradesh
The successful completion of the global Phase 3 trials paves the way to obtain marketing approval in the U.S. and EU
Subscribe To Our Newsletter & Stay Updated
